• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Occupational exposure to aerosolized pentamidine.

作者信息

Montgomery A B, Corkery K J, Brunette E R, Leoung G S, Waskin H, Debs R J

机构信息

Medical Service, San Francisco General Hospital Medical Center.

出版信息

Chest. 1990 Aug;98(2):386-8. doi: 10.1378/chest.98.2.386.

DOI:10.1378/chest.98.2.386
PMID:2376170
Abstract

Occupational exposure to aerosolized pentamidine has raised questions regarding transmission of tuberculosis and the effect of the drug itself. To estimate the exposure of a health care worker, we measured the ambient concentration of aerosolized pentamidine in field conditions in 36 m3 unventilated treatment room. The amount of pentamidine averaged in three different environmental air samples over a four-hour period was 4.5 +/- 3.6 x 10(-5) mg/m3. This amount is very small compared to the doses received by the patients in whom long-term adverse effects are few. The greater risk to health care workers is probably transmission of tuberculosis from undiagnosed cases, especially in populations with an increased incidence of tuberculosis. Tuberculosis control measures such as improved ventilation and masks should also decrease exposure to ambient air pentamidine until toxicity studies determine long-term adverse effects, if any, of aerosolized pentamidine.

摘要

相似文献

1
Occupational exposure to aerosolized pentamidine.
Chest. 1990 Aug;98(2):386-8. doi: 10.1378/chest.98.2.386.
2
Respiratory effects of occupational exposure to aerosolized pentamidine.
J Occup Environ Med. 1995 Feb;37(2):145-50. doi: 10.1097/00043764-199502000-00013.
3
Spontaneous pneumothorax in AIDS patients with recurrent Pneumocystis carinii pneumonia despite aerosolized pentamidine prophylaxis.
Chest. 1991 Feb;99(2):502-4. doi: 10.1378/chest.99.2.502.
4
Exposure of health care workers to aerosolized pentamidine.医护人员接触雾化戊烷脒。
Chest. 1992 Jun;101(6):1494-9. doi: 10.1378/chest.101.6.1494.
5
Spontaneous pneumothorax in patients with acquired immunodeficiency syndrome treated with prophylactic aerosolized pentamidine.接受预防性雾化喷他脒治疗的获得性免疫缺陷综合征患者的自发性气胸
Arch Intern Med. 1990 Oct;150(10):2167-8.
6
Efficacy of engineering controls in reducing occupational exposure to aerosolized pentamidine.工程控制措施在减少职业性接触雾化戊烷脒方面的效果。
Chest. 1992 Dec;102(6):1764-6. doi: 10.1378/chest.102.6.1764.
7
Aerosolized pentamidine as second line therapy in patients with AIDS and Pneumocystis carinii pneumonia.雾化喷他脒作为艾滋病合并卡氏肺孢子虫肺炎患者的二线治疗方法。
Chest. 1989 Apr;95(4):747-50. doi: 10.1378/chest.95.4.747.
8
Apical Pneumocystis carinii pneumonia in AIDS patients not receiving inhaled pentamidine prophylaxis.未接受吸入性喷他脒预防治疗的艾滋病患者的肺尖卡氏肺孢子虫肺炎
Chest. 1991 Nov;100(5):1462-4. doi: 10.1378/chest.100.5.1462.
9
Pneumocystis hepatitis and choroiditis despite successful aerosolized pentamidine pulmonary prophylaxis.
Chest. 1989 Oct;96(4):949-51. doi: 10.1378/chest.96.4.949.
10
A controlled trial of trimethoprim-sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trials Group Protocol 021.一项关于甲氧苄啶-磺胺甲恶唑或雾化喷他脒对获得性免疫缺陷综合征患者卡氏肺孢子虫肺炎二级预防的对照试验。艾滋病临床试验组方案021。
N Engl J Med. 1992 Dec 24;327(26):1842-8. doi: 10.1056/NEJM199212243272604.

引用本文的文献

1
Precautionary Practices of Respiratory Therapists and Other Health-Care Practitioners Who Administer Aerosolized Medications.使用雾化药物的呼吸治疗师及其他医护人员的预防措施。
Respir Care. 2015 Oct;60(10):1409-17. doi: 10.4187/respcare.03817. Epub 2015 Jul 7.
2
A Workflow to Investigate Exposure and Pharmacokinetic Influences on High-Throughput in Vitro Chemical Screening Based on Adverse Outcome Pathways.一种基于不良结局途径研究暴露和药代动力学对高通量体外化学筛选影响的工作流程。
Environ Health Perspect. 2016 Jan;124(1):53-60. doi: 10.1289/ehp.1409450. Epub 2015 May 15.